134 related articles for article (PubMed ID: 17178869)
1. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies.
Martinive P; Defresne F; Bouzin C; Saliez J; Lair F; Grégoire V; Michiels C; Dessy C; Feron O
Cancer Res; 2006 Dec; 66(24):11736-44. PubMed ID: 17178869
[TBL] [Abstract][Full Text] [Related]
2. Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells--new insights for anti-tumor treatments.
Martinive P; Defresne F; Quaghebeur E; Daneau G; Crokart N; Grégoire V; Gallez B; Dessy C; Feron O
FEBS J; 2009 Jan; 276(2):509-18. PubMed ID: 19077164
[TBL] [Abstract][Full Text] [Related]
3. Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases.
Daneau G; Boidot R; Martinive P; Feron O
Clin Cancer Res; 2010 Jan; 16(2):410-9. PubMed ID: 20068092
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor cell growth in the liver by RNA interference-mediated suppression of HIF-1alpha expression in tumor cells and hepatocytes.
Takahashi Y; Nishikawa M; Takakura Y
Gene Ther; 2008 Apr; 15(8):572-82. PubMed ID: 18273056
[TBL] [Abstract][Full Text] [Related]
5. Significance of HIF-1-active cells in angiogenesis and radioresistance.
Harada H; Kizaka-Kondoh S; Li G; Itasaka S; Shibuya K; Inoue M; Hiraoka M
Oncogene; 2007 Nov; 26(54):7508-16. PubMed ID: 17563752
[TBL] [Abstract][Full Text] [Related]
6. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
7. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
[TBL] [Abstract][Full Text] [Related]
8. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
Hao J; Song X; Song B; Liu Y; Wei L; Wang X; Yu J
Cancer Gene Ther; 2008 Jul; 15(7):449-55. PubMed ID: 18421307
[TBL] [Abstract][Full Text] [Related]
9. Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1.
Toffoli S; Roegiers A; Feron O; Van Steenbrugge M; Ninane N; Raes M; Michiels C
Angiogenesis; 2009; 12(1):47-67. PubMed ID: 19184477
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-reoxygenation-induced chemokine transcription is not prevented by preconditioning or intermittent hypoxia, in mice hepatocytes.
Laurens M; Defamie V; Scozzari G; Schmid-Alliana A; Gugenheim J; Crenesse D
Transpl Int; 2005 Apr; 18(4):444-52. PubMed ID: 15773965
[TBL] [Abstract][Full Text] [Related]
11. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
12. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
Gillespie DL; Whang K; Ragel BT; Flynn JR; Kelly DA; Jensen RL
Clin Cancer Res; 2007 Apr; 13(8):2441-8. PubMed ID: 17438103
[TBL] [Abstract][Full Text] [Related]
13. [Over-expression of hypoxia-inducible factor 1 alpha increases angiogenesis of LNCaP cells in vivo].
Han YL; He DL; Luo Y; Cheng HP; Zhu GF
Zhonghua Nan Ke Xue; 2008 May; 14(5):439-44. PubMed ID: 18572865
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow.
Lévesque JP; Winkler IG; Hendy J; Williams B; Helwani F; Barbier V; Nowlan B; Nilsson SK
Stem Cells; 2007 Aug; 25(8):1954-65. PubMed ID: 17478585
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
[TBL] [Abstract][Full Text] [Related]
18. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
19. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
